Daiki Hiratsuka

ORCID: 0000-0001-7128-2859 · 12 papers in corpus
review 2026
Reproductive medicine and biology ·doi:10.1002/rmb2.70040

BACKGROUND: Recurrent implantation failure (RIF) is an infertility condition in which uterine factors remain difficult to diagnose and treat. Recent studies implicate the endometrial microbiome in implantation. METHODS: This clinically ori…

observational 2026
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2026.105699

RESEARCH QUESTION: Does adenomyosis increase the risk of thromboembolic events, including both arterial and venous thromboembolism, compared with endometriosis, and what clinical factors may contribute to this association? DESIGN: This ret…

review 2026
Fertility and sterility ·doi:10.1016/j.fertnstert.2026.01.010

The reproductive tract microbiome plays a pivotal role in female fertility, with Lactobacillus-dominated communities maintaining a protective, low-pH environment. Dysbiosis-characterized by a reduction in Lactobacillus species and overgrowt…

lab-animal 2026
Journal of the Endocrine Society ·doi:10.1210/jendso/bvag056

Adenomyosis is an intractable gynecological disorder that can give rise to severe pelvic pain, heavy menstrual bleeding, and infertility, predominantly affecting women of reproductive age. The limited efficacy of current pharmacological int…

other 2026
Reproductive medicine and biology ·doi:10.1002/rmb2.70028

PURPOSE: Recurrent implantation failure (RIF) is a form of refractory infertility that persists despite assisted reproductive technology. Cine magnetic resonance imaging (cine MRI) enables the visualization of uterine peristalsis; however, …

other 2025
Scientific reports ·doi:10.1038/s41598-025-92906-9

Chronic endometritis (CE) and endometrial dysbiosis (ED) are major causes of recurrent implantation failure (RIF). CE is diagnosed via hysteroscopy or the endometrial CD138 test; ED is examined using endometrial microbiome testing with next…

other 2025
BMC women's health ·doi:10.1186/s12905-025-03817-w

Adenomyosis often causes dysmenorrhea in women of reproductive age. Progestins such as levonorgestrel intrauterine system (LNG-IUS) are often used for treatment, but some patients experience progesterone resistance, showing poor treatment r…

2025
·doi:10.32388/k8kcsx

As stated in the discussion, endometriosis is generally managed not only with surgical excision but also with hormonal therapy.Since the patient also experienced dysmenorrhea, it is worth noting whether hormonal therapy was considered or no…

case-report 2024
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.16185

Uterine adenomyosis is a common disease in women of reproductive age that causes dysmenorrhea, abnormal uterine bleeding, infertility, and obstetric complications. Rarely, adenomyosis can lead to abscess formation, which is refractory to an…

observational 2023
European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2023.100187

OBJECTIVE: With the increased use of total laparoscopic hysterectomy (TLH), the use of robotic-assisted laparoscopic hysterectomy (RALH) has increased due to its technical advantages. On the other hand, RALH has some disadvantages, includin…

observational 2023
BMC pregnancy and childbirth ·doi:10.1186/s12884-023-05956-0

BACKGROUND: Adenomyosis is a common gynecological disease in women of reproductive age and causes various symptoms such as dysmenorrhea and heavy menstrual bleeding. However, the influence of pregnancy on the progression of adenomyosis rema…

observational 2022
European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2022.100162

OBJECTIVE: To reduce intraoperative blood loss in laparoscopic myomectomy, uterine artery occlusion or temporary uterine artery clipping have been employed. Recently, in addition to these techniques, temporary uterine artery ligation has be…